Table 1.
Agent * | Signal Molecule | Cell ** | References |
---|---|---|---|
Up-regulation | |||
Ethoxyquin | Nrf2 | Lung cancer A549, H23 | [14] |
MG-132, bortezomib | Nrf2 | CRC SW-480, HT29 | [17] |
Doxorubicin | Nrf2 | Gastric cancer MKN45 | [18] |
EGF, insulin | AP-1, ERK | HCC HepG2, Hep3B | [19] |
Lipopolysaccharide | Blood mononuclear cells | [20] | |
BMP, IBMX | Mesenchymal stem cells | [21] | |
9,10-Phenanthrenequinone | Nrf2, ERK | Lung cancer A549 | [22] |
Cigarette smoke extract | Airway epithelium | [23] | |
Carnosic acid, t-BHQ | Nrf2 | Astrocytoma U373MG | [15] |
5-FU, L-OHP | p53 | CRC HT116 | [16] |
Down-regulation | |||
TPA | c-Jun, ERK | Lung cancer A549 | [15] |
5-FU, L-OHP | CRC HT29 | [16] |
Note: * Abbreviations of agents: EGF; epidermal growth factor, BMP, bone morphogenetic protein 2; IBMX, 3-isobutyl-1-methylxanthine; t-BHQ, t-butyl hydroquinone; 5-FU, 5-fluorouracil; L-OHP, oxaliplatin; TPA, 12-O-tetradecanoylphorbol 13-acetate. ** Abbreviations of cancer: CRC, colorectal cancer; HCC, hepatocellular cancer.